Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-08-14
2007-08-14
Hayes, Robert C. (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
Reexamination Certificate
active
10890508
ABSTRACT:
A method for diagnosing distinct subgroups of Alzheimer's Disease, the method comprising the steps of obtaining a sample of cerebrospinal fluid and determining the level of ubiquitin, the level of Aβ1-42, and the level of tau present in the sample. Based on the levels of each composition in the cerebrospinal fluid, the sample can be assigned to distinct subgroups.
REFERENCES:
patent: 5272055 (1993-12-01), Haley
patent: 5445937 (1995-08-01), Haley
patent: 5508167 (1996-04-01), Roses et al.
patent: 5994084 (1999-11-01), Anderson et al.
patent: 6451547 (2002-09-01), Jackowski et al.
patent: 6495335 (2002-12-01), Chojkier et al.
Hu 2002. American Journal of Pathology 160:1269-1278.
Iqbal 2002. Tatl tau, A beta (1-42) and ubiquitin in CSF in the diagnosis of Alzheimer disease European Psychiatry 17(1):p. 76S.
Flory Michael
Grundke-Ighal Inge
Iqbal Khalid
Bond Schoeneck & King , PLLC
Hayes Robert C.
Kolker Daniel E.
Nocilly David L.
The Research Foundation for Mental Hygiene, Inc.
LandOfFree
Method for differentiation of Alzheimer's Disease into... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for differentiation of Alzheimer's Disease into..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for differentiation of Alzheimer's Disease into... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3842671